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Accepted 30 March 2011AbstractFemale dyspareunia is a serious impairment with a prevalence of up to 39.5%, imposing a significant burden on women’s health, relationship,
and quality of life. Because the causes of female dyspareunia are associated with multiple biological, medical, psychological, sociocultural, and
interpersonal dimensions, all members of the health team should help fill this gap in the total care of the patient. The nurse is an ideal member of
the health team to counsel patients in the sensitive and highly charged area of human sexuality. The purpose of this article was to explore the
essential components of female dyspareunia from nursing care perspective to help women suffering from dyspareunia. The article provides a set
of tools, including description and clinical presentation, obtaining a history and clinical data for the evaluation of dyspareunia, and a counseling
tool of the Permission, Limited Information, Specific Suggestions, and Intensive Therapy model; suggestions are also provided for health care
professionals during the treatment process.
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Most of the health care providers have proposed that dis-
cussing sexual issues with their patients should be their
responsibility and duty [1e4]. However, data reveal that few
are addressing the sexual issues with their patients. In the
United States, only 9% of the patients aged 40e80 years have
been asked about sexual concerns by their physicians [1].
Also, another study on urogynecologists found that, though
most stated screening for female sexual dysfunction is some-
what or very important, only 22% have always screened for
female sexual dysfunction, and 23% have never or rarely done
it [4]. Reasons of their reluctance include “sexual problems are
too biopsychosocial complex and take much time to unravel”;
“sex is not identified as a priority or as relevant to the patient’s* Corresponding author. Department of Obstetrics and Gynecology, BenQ
Medical Center, 71Hexi Avenue, JianyeDistrict, Nanjing, Jiangsu 210019,China.
E-mail address: jengcj@gmail.com (C.-J. Jeng).
1028-4559/$ - see front matter Copyright  2011, Taiwan Association of Obstetri
doi:10.1016/j.tjog.2011.07.002presenting problems”; “the physician is personal discomfort
with the sexual topics”; “the physician lacks of knowledge or
skills dealing with patient’s sexual problems” [5]. In Japan,
32.4% of doctors have been consulted about sexual issues by
patients or families, but their attitude toward sex-related
statements show that, although most recognize the importance
of patients’ sexuality-related concerns, they do not necessarily
think that they have a professional responsibility to deal with
the sexual issues [2]. A study in Taiwan reveals that 77.9% of
nurses seldom or have never provided nursing assessment on
sexual health; 43.1% seldom discuss patients’ sexual diffi-
culties with them. Regarding nurses’ attitudes on discussing
patients’ sexual difficulties with them, about 74.8% of nurses
would talk to the patients only when the patients propose to do
so, and about 58.3% of nurses experienced patients’ requests
for discussions on sexual difficulties [3]. Tsai [6] found that
the two major perceived desire facilitators for a nurse to know
a patient’s sexual history are related to the patient’s illness and
when the patient specifically mentions the sexual problems; oncs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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to discuss his or her sexual history are the patient’s embar-
rassment discussing the issues of sexuality or the patient’s
perception of no association of his or her treatment with his or
her sexuality and a lack of professionals for referral for further
consultations. A similar study conducted in Sweden found that
nurses feel that their patients could be upset (67%), embar-
rassed (72%), or anxious (68%) if they are asked about sexual
concerns [7]. Moreover, in the current clinical environments
with constraints on the amount of time that can be spent with
each patient, individuals will not likely have their sexual
concerns addressed during a standard medical encounter [8].
Dyspareunia is the symptom with persistent and recurrent
urogenital pain occurring before, during, or after sexual
intercourse because of physical or psychological causes. It is
reported most typically as a unique problem to women,
although it can also occur in men with a relatively rare
instance [9]. Dyspareunia has been identified as the most
common sexual complaint in women spontaneously reported
to gynecologists [10]. In women, common physical causes of
dyspareunia include interstitial cystitis, irritable bowel
syndrome, pelvic inflammatory disease, chronic pelvic pain,
and endometriosis [11]; psychological causes result from fear
of pain, interpersonal disturbance, and sexual abuse [12e15].
Women experiencing dyspareunia will report higher levels of
catastrophizing; fear of pain; hypervigilance [12]; and mood
disturbance, such as nervousness and depression [15]. More-
over, dyspareunia may place a woman at risk for the devel-
opment of vaginismus as well as secondary desire, arousal,
and orgasmic dysfunctions [16]. The prevalence of dyspar-
eunia in women is found to be 8e39.5% [15,17,18].
Because female dyspareunia is a complex problem, associated
with multiple biological, medical, psychological, sociocultural,
and interpersonal dimensions, patients typically seek several
clinicians in an effort to evaluate and treat their conditions. In an
online study of 428 women experiencing vulvar pain [19], about
50% reported to have consulted four to nine physicians during the
treatment process because 57% reported that their pain had
stayed the same or worsened since initiating treatment and only
40% trusted their current physician to manage the pain. There-
fore, clinicians, nurses, and other health care providers should
help fill this gap in the total care of the patient by initializing
conversations with the patient. The health care provider’s back-
ground reflects education in the physical, social, and behavioral
sciences, as well as theory and practice in counseling techniques.
To counsel patients in the highly sensitive area of human sexu-
ality, knowing how to use communication skills and expressing
a supportive attitude to approach patients and establish a trust
relationship would be an important task to health care providers.
The purpose of this article was to explore the essential
components of female dyspareunia to help women suffering
from dyspareunia. The article provides a set of tools, including
description and clinical presentation, obtaining a history and
clinical data for the evaluation of dyspareunia, and a tool of
the Permission, Limited Information, Specific Suggestions, and
Intensive Therapy (PLISSIT) model; suggestions are also
provided for health care providers during the treatment process.Description and clinical presentation
Pain is a subjective experience with the heterogeneity of its
etiology, and therefore, careful measurement and description
of pain is necessary. Dyspareunia is defined as persistent and
recurrent urogenital pain occurring before, during, or after
sexual intercourse, which is not caused exclusively by lack of
lubrication or by vaginismus [9]. It cannot be accounted for by
another Axis I disorder (except another sexual dysfunction)
and cannot be attributed to the direct physiological effects of
a substance (e.g. a drug of abuse, a medication) or a general
medical condition [20].
The prevalence of dyspareunia inwomen has been found to be
varying between 8% and 39.5% [15,17,18]. This variation is
caused by the following factors: inconsistent use of case defini-
tions, variation in study design and conduct, and different
outcome measures used to assess dyspareunia [21]. Therefore,
developing an understanding of what is considered “dyspar-
eunia” is important and can help determine the range of condi-
tions causing a patient to experience sexual difficulties within
the sexual issues. The American Psychiatric Association’s
Diagnostic and Statistical Manual of Mental Disorders, 4th
Edition (DSM-IV) [20] and the World Health Organization’s
International Classification of Disease, 10th revision (ICD-10)
[22] define dyspareunia as pain associated with sexual inter-
course. However, Basson et al [23] propose that dyspareunia
should include pain with attempted or completed vaginal entry.
Binik [24] also points out that dyspareunia should be defined as
the experience of pain during sexual intercourse and/or
nonsexual pain with vaginal penetration. DSM-IV and ICD-10
stipulate that sexual pain should not be classified from “general
medical conditions” or “local pathology” and exclude sexual
pain because of lubrication problems. In addition, diagnostic
systems usually classify dyspareunia and vaginismus as separate,
mutually exclusive sexual dysfunctions [21]. Furthermore, dys-
pareunia is highly comorbid with other treatment-resistant pain-
related conditions, such as interstitial cystitis, irritable bowel
syndrome, pelvic inflammatory disease, chronic pelvic pain,
endometriosis, or a history of sexually transmitted disease/pelvic
inflammatory disease, chronic urinary tract infection, colitis, and
sexual abuse [11,13].
Women with dyspareunia may have pain with localized
or generalized genital contact, and the most common type
of dyspareunia is vulvodynia that occurs in the absence of
physical findings or a specific disorder [9]. Vulvodynia is
divided into two main categories based on the vulvar area
affected by the pain. Localized vulvodynia refers to pain in
one vulvar area (e.g. vestibule), and generalized vulvodynia
refers to pain over the entire vulvar region. Each category is
further subdivided into provoked (i.e. it occurs in response to
stimulation of the affected area), unprovoked (i.e. it occurs
independent of stimulation), or mixed temporal pain patterns.
Provoked pain, which is called provoked vestibulodynia
(PVD) (formerly termed as vulvar vestibulitis syndrome), can
occur during sexual, nonsexual, or both kinds of activities
[25]. PVD is believed to be the most frequent cause of vul-
vodynia in women of childbearing age, with a prevalence rate
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course is the defining symptom of PVD and is often the
patient’s presenting complaint. It can be present from coi-
tarche (i.e. the first intercourse attempt and the primary PVD)
or it may develop after a period of pain-free intercourse (i.e.
secondary PVD) [25e27].
In addition to physical pain, a woman’s experience of
dyspareunia is usually more complicated, associated with
psychological, sexual, and interpersonal disturbances. She may
experience embarrassment, shame, guilt, loss of self-esteem,
frustration, anxiety, nervousness, depression [14,15], and/or
diminishing sexual satisfaction [28]. Also, a woman’s cognitive
and emotional response may exacerbate pain or increase inter-
course pain intensity by greater catastrophizing, fear of pain,
and hypervigilance, in addition to lower self-efficacy [12].
Obtaining a history and clinical data for the evaluation of
dyspareunia
It is essential that a thorough patient baseline assessment,
including medication history, physical evaluation, and
psychological evaluation, shall be completed for each dys-
pareunia patient before any treatment interventions are initi-
ated. It is noted that the initial discussion with the patients is of
upmost importance as some problems can be handled without
referral. In obtaining a history and clinical data process,
information is obtained from the patient in a direct and struc-
tured manner through observations, interviews, and physical/
psychological examinations. For a thorough sexual history,
medical, reproductive, surgical, psychiatric, social, and sexual
information should be included. Relevant content would
include a past medical history, current health status, repro-
ductive history, endocrine system review, thyroid conditions,
and psychiatric illness [9]. In addition to a general medical,
psychophysiological, and sexual history, the multidisciplinary
assessment should ascertain the following: (1) the location,
quality, intensity, and duration of the pain; (2) circumstances in
which pain is noticeable, including both sexual and nonsexual
situations; (3) the perception of muscle tension in sexual and
nonsexual situations; (4) changes that the woman and her
partners have made to sexual activity to limit or control pain;
(5) the degree to which the woman experiences sexual arousal
in sexual situations, both with regard to subjective excitement
and to genital sensations and lubrication; and (6) the motivation
and expectations of treatment, especially for the direct contact
the genitals [29]. Holistic health care requires the health care
providers to complete an assessment of the patient’s biological,
psychological, and sociocultural health status. Through this
process, the health care providers should respect the individ-
ual’s autonomy and accept the patient’s subjective experience,
and focus on the patient’s problem and determine her motiva-
tion for treatment.PreparationThe assessment process is an interactive, systematic, and
individualized way to achieve the outcomes of health care.Therefore, during preparation, the health care provider’s task
is to establish a climate of trust, understanding, and acceptance
relationship. To achieve this goal, the health care providers
must take care of environment and time constraints when
obtaining a sexual history. During the interview interaction,
the health care providers should refrain from being either too
formal or too casual when obtaining the medical or sexual
history and make sure that the patient is in a comfortable and
relaxed position face to face with the health care providers.
The health care providers should feel comfortable using sexual
terminology (e.g. vagina, penis, orgasm, and others) and be
ready to listen actively. The health care providers should be
sensitive on behaviors of communication because the behav-
iors can either facilitate the development of a therapeutic
relationship or serve as a barrier to it. Behaviors of commu-
nication include individual’s eye contact, facial expression,
speech tone, gesture, position, and statement; especially, the
use of eye contact is vital in gaining the individual’s trust and
confidence. For the environment preparation, private setting is
crucial in making a comfortable exchange of information as
the patient is being asked the most intimate and detailed
questions of her private life. Moreover, it is suggested that no
desk be placed between the patient and the health care
providers as this may create a feeling of a boundary to the
discussion [8].Medication historyThe pharmacological assessment should be integrated with
the principles of the assessment process. The health care
provider is in a pivotal position to educate the patient and her
family about medications and to coordinate the treatment
modalities. Many prescribed medications, such as selective
serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine
reuptake inhibitors (SNRIs), monoamine oxidase inhibitors
(MAOIs), antipsychotics, benzodiazepines (BZD), beta-
blockers, alpha-blockers, diuretics, digoxin, histamine H2-
receptor blockers, anticonvulsants, and steroids, have sexual
side effects [9]. Therefore, it is essential to develop a timeline
of medication use to compare with the timeline of the patient’s
sexual pain history. Because the patient may be taking other
prescription medication, a discussion of the patient’s current
use of medicine, including prescription drugs, over-the-
counter medications, and alterative medicines, should also
be identified. Because of the specific Taiwanese culture, herbal
supplements, such as traditional Chinese medicine, herbs,
vitamins, folk therapy, and alternative therapies, should be
recorded during the medication history. Furthermore, although
antibiotics, which are the most common prescription medi-
cation that women use, do not directly cause sexual pain, its
long-term exposure will predispose women to chronic yeast
infections, which may be a causative agent of the pain [14].
Hormonal influence from oral contraceptive has, among other
things, been suggested as a causative factor for vulvar vesti-
bulitis [30] and is identified as the most common cause of
dyspareunia in premenopausal women [14]. Psychotropic
medications are more frequently implicated as a cause of
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disorder than sexual pain [31]. Both hypoactive sexual desire
disorder and female sexual arousal disorder can contribute to
dyspareunia because of their effects on vaginal lubrication
[14]. Therefore, medication assessment and education are
important key points to the effective and safe use of prescribed
medications, to patient collaboration in the treatment plan, and
to patient adherence with drug treatment regimens.Physical evaluationPhysical evaluation is mandatory during assessment of
dyspareunia. Genital pain may result from a variety of medical
conditions and anatomical variations that should be ruled out
by physical examination. Therefore, a woman with dyspar-
eunia should undergo a thorough physical examination to
collect data for determining the potential etiology of the sexual
pain. It is highly recommended that the procedure is explained
in detail to the patient (i.e. what will and will not occur), and
the patient’s understanding and consent is obtained [23].
Colposcopic examination of the vulva, commonly referred
to as vulvoscopy, in a woman with sexual pain, may be
needed. A sensory examination is performed using moistened
cotton swab to determine if there are areas that exhibit an
abnormal pain response. This examination should be per-
formed systematically to ensure that all areas of the anogenital
region are tested. The labia majora, clitoral prepuce, perineum,
and intralabial sulci should then be palpated. A speculum
examination of vagina is the next step. In general, a pediatric-
sized Graves speculum should be used, and all efforts should
be made to insert the speculum through the hymeneal ring
without touching the vulvar vestibule. A manual examination
should also be performed with one finger instead of the usual
two fingers. The examiner’s index finger is inserted through
the hymen without touching the vestibule. Moreover, the
vaginal discharge may need to be examined with microscopy
and culture as infection is one potential cause of dyspareunia
[23]. Thus, a cotton swab should be used to collect some
discharge for pH testing, wet mount, and potassium hydroxide
testing. In addition, culture should be obtained and sent for
speciation and sensitivity [14]. Serum testing is not necessary
in all cases of sexual pain, but because hormonal abnormalities
are common causes of sexual pain, blood should be obtained to
examine the levels of serum estradiol, total testosterone, free
testosterone, albumin, sex hormoneebinding globulin, follicle-
stimulating hormone, and prolactin [14,32]. A decreased serum
estradiol is frequently found in a woman with vestibulodynia or
atrophic vaginitis [14].Psychological evaluationBecause the experience of pain includes sensory and
affective aspects, the clinical interview has to cover multiple
areas affected by dyspareunia to elicit descriptions important
to treatment planning. A comprehensive psychological evalu-
ation can provide valuable information about predisposing
factors, such as family of the original and cultural schemaabout sexuality, sexual experiences, and any history of sexual
abuse/trauma [33]. This evaluation brings another perspective
to the health care providers with an unbiased receptivity to
patients and their problems.
The assessment of pain properties, mediators, interference,
comorbid disorders, and self-reported effectiveness of past
treatment attempts can be preceded during the psychological
evaluation. For pain properties, it is important to collect the
lifetime onset of the pain (the onset within an intercourse
episode, duration of the pain, and its specific location) with
qualitative descriptions and the severity of pain, which can be
elicited by means of visual analog or numerical rating scales.
For pain mediator, it is focused on examining what tends to
exacerbate or improve the pain. Some potential mediators
include length of foreplay, intercourse positions, use of
lubrication aids, level of desire/arousal, timing, fatigue, stress,
mood, feelings toward the sexual partner, and overall rela-
tionship quality. For pain interference and comorbid problems,
the comorbidity of other sexual dysfunctions, mood distur-
bances, and relationship difficulties should be relatively well
documented, although it can be difficult to separate cause and
consequence [33]. This is because a woman experiencing
dyspareunia is reported to have higher levels of catastrophiz-
ing; fear of pain; hypervigilance [12]; and mood disturbance,
such as nervousness and depression [15], and pain intensity
has a significant association with marital adjustment, partner
solicitousness, and partner hostility [12].
For self-administrated measures, sexuality questionnaires
play an integral role in the diagnosis and treatment and
provide specific indicators for evaluating the outcomes of
treatment of female dyspareunia [9,33,34]. The defining
characteristics of sexuality questionnaires are particularly
helpful because they often reflect the behaviors that are the
target of clinical intervention and research. The questionnaires
can include (1) the McGill-Melazack Pain Questionnaire to
assess the severity of pain in dyspareunic women; (2) Changes
Sexual Functioning Questionnaire, Female Sexual Function
Index, McCoy Female Sexuality Questionnaire, and Female
Sexual Distress Scale to identify/diagnose individuals with
sexual dysfunction; and (3) Golombok-Rust Inventory of
Sexual Satisfaction (GRISS) and The Sexual Satisfaction
Scale for Women to measure improvement or satisfaction with
treatment. If depression or anxiety is suspected, the Back
Anxiety Inventory can be used because it is psychometrically
sound and brief.
The PLISSIT model for sexual counseling
To address patients’ concerns about sexuality effectively,
the health care providers need to learn how to approach
sexuality as they act proactively in providing opportunities for
patients to present concerns. For example, even when physi-
cians are comfortable about initiating sexual inquiry, they may
tend to overemphasize the biological basis of problems and
neglect the psychological, interpersonal, and cultural deter-
minants of difficulties [16]. Therefore, sexual-counseling
strategies can be used by the health care providers during the
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sexual-counseling frameworks [16,36e43] are available for
health care providers to use as supportive and effective strat-
egies to conduct sexual intervention in clinical practice. It is
recommended by the authors to use the PLISSIT model for
sexual counseling on a woman experiencing dyspareunia
because the model has been used extensively in clinical
practice [5,8,35,36,38,43e49] and can easily be incorporated
into routine practice to assist the health care providers in
gradually discussing the topic of sexual health and providing
short-term supportive counseling [5,8,43e46,49]. The PLIS-
SIT model, which consists of four levels of counseling
(Permission, Limited Information, Specific Suggestions, and
Intensive Therapy), was developed by Annon [38] for use by
the health care providers in meeting the sexuality and sexual
health care needs of patients (Table 1). By providing this
support, the health care providers can help patients to know
and understand their own abilities and disabilities brought on
by their experiences of illness or surgery, allowing them to
adjust accordingly. The details of how to apply the PLISSIT
model by the health care providers on a woman experiencing
dyspareunia are described as follows.PermissionPermission is the first level of the model giving the patient
permission to initiate sexual discussion and empowering her to
make choices and changes [5,38]. When performing the
assessment, the health care providers create a comfortable and
open-minded climate, demonstrate active listening, freely
interact with the patient and her partner, simply ask questions
about all aspects of sexual health to give the patient the
opportunity (permission) to share her sexuality and what it
means to them, and identify any concerns. However, the
woman may hesitate or feel embarrassed to describe her
sexual problems; therefore, it is important to explain that
sexuality is an essential quality-of-life issue, and that you are
open to discuss it. This helps to normalize the discussion andTable 1
The PLISSIT sexual-counseling model
Permission:
 Give the patient the permission to initiate sexual discussion and empower
the patient to make choices and changes.
 All health care providers should be able to function at this level.
Limited Information:
 Provide factual information to the patient in response to a question or
observation.
 Most health care providers should be able to give this type of information.
Specific Suggestions:
 Explain the causes of the problems to the patient and assist the patient with
very specific directions on how to address the problems.
 Most health care providers should be able to function at this level.
Intensive Therapy:
 Provide the patient the treatment for severe or more longstanding problem
of dyspareunia.
 The health care providers need to be trained to identify situations that
require intensive therapy and to make appropriate medical referrals when
necessary.may help the patient feel less embarrassed or alone. When
a patient is not ready to deal with her sexual issues, the health
care providers can acknowledge that the time might not seem
appropriate now and the patient could ask for information any
time. Moreover, the woman may have several different
complaints; hence, it will be important to understand her
perspective of pain, clarify her expectations, and further
determine which of these she feels is her main complaint.
Therefore, the process should be focused but open ended,
progressing from general to specific and allowing spontaneous
patient self-expression. The common questions can be started
by “What concerns do you have about your sexual functioning
or sex life?”; “Are you having any sexual difficulties at this
time?”; and “Do you have pain during or after sex?” The
health care provider’s role is to maintain the flow of the
interview and to listen to the verbal and nonverbal messages
conveyed by the patient. All health care providers also must be
aware of their responses to the patient [37,39,49] and should
be able to function at this level.Limited informationThe second level, Limited Information, refers to factual
information given to the patient in response to a question or
observation. The health care providers address prevalent sexual
concerns, norms of behavior, and attempt to correct myths and
misinformation. This is reserved for relatively straightforward
and noncomplex problems [8]. For instance, women often
believe sex pain tolerance will meet their partners’ needs [28],
or some women have a very difficult time localizing their
sexual pain or actual areas affected by the pain. They may not
seek help and try to avoid disclosure about the nature of the
problem or incorrectly identify the location of their dyspar-
eunia. It is not surprising to find that a patient localizes the pain
to the vagina, but an examination reveals that the pain origi-
nates from the vulva or bladders [14]. The health care providers
can teach the basic anatomy of the genital organ and physio-
logical response of sexual function, and explain to the patients
how disease or treatment may affect sexual functioning and
what changes in anatomy occur after surgery or birth delivery.
Moreover, the health care providers can emphasize the
importance of communication and trust within a partner rela-
tionship; dispel misconceptions and lead to the sharing of
accurate information; and review the needs for sexual health,
comfort, belief, and emotional safety [5,36]. Most health care
providers should be able to give this type of information.Specific suggestionsSpecific Suggestions is the third level of PLISSIT and
involves making a specific suggestion to the woman, which
requires a deeper level of expertise. After explaining the
sexual concerns and how a woman has evolved over time, the
health care providers may explain the causes of the problems
and assist the woman with very specific directions on how to
address the problems. These suggestions include telling the
patient what she can do for herself and what other patients
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and/or psychological intervention (e.g. prescriptions, exercise,
multimedia aids) and alternative methods of sexual expression
[8,36]. For example, Kegel exercises may be suggested to help
the patient relax her pelvic floor muscles. During the process
of providing guidance to the patient, the health care providers
can give the patient responsibility and encourage her active
involvement in finding a solution that becomes internalized to
her. It is essential that, during the sexual-counseling process,
the health care providers and the patient emerge as partners in
a relationship built on trust and directed toward maximizing
the patient’s strengths, maintaining integrity, and promoting
adaptive responses to her problems. Moreover, sexual satisfac-
tion is strongly positively correlated with sexual communication
between the woman with dyspareunia and her sexual partner
[28], and therefore, assessing the couple’s sexual communica-
tion and providing alternative methods of sexual expression are
needed and are important. These suggestions may include
focusing on sexual sensations; recording negative thoughts and
analyzing them when sexual pain occurs; teaching the couple to
engage in extended foreplay as it can help lengthen the vagina
before penetration; usingmusic, candles, and incense to enhance
the sexual experience; using water-based vaginal lubricants
during foreplay and penetration and vaginal moisturizers; using
mutually agreed upon fantasies; and using stimulating devices
[8,28,38].Intensive therapyFor the fourth level of Intensive Therapy, the patient needs
intensive therapy for severe or more longstanding problem of
dyspareunia. In this level, the treatment may include psychiatric
diagnoses, such as depression, anxiety disorder, personality
disorders, or substance abuse, or by interpersonal or intraper-
sonal conflict [8,48], and specialized treatment (e.g. marital or
couple counseling, or in-depth psychotherapy) may be needed
in cases that are complicated by the coexistence of other
complex life issues. However, the health care providers need to
be trained to identify situations that require intensive therapy
and to make appropriate medical referrals when necessary [38].
Sometimes, the “homework” assignments are needed in
a counseling session for the couple, or individual, to practice
what was discussed and learnt in the session. For example, the
patient can be taught “the giving and receiving pleasure of
sensate focus” in individual or mutual pleasuring. The
assignments are intended to turn the idea of sexual obligation
into pleasure; learn to focus on sensations rather than anxi-
eties, fears, or penetration; and encourage the patient to be
open, honest, and express feelings, needs, or frustration during
the practice process. The couple may be asked to deliberately
avoid orgasm, penetration, or even touching sexual organs
during the practice process [8].
Conclusion
Female dyspareunia is an underrecognized and poorly
treated constellation of disorder with prevalence of up to 39.5%that significantly impacts the affected women and their partners.
Because women experiencing dyspareunia would experience
a variety of sexual health difficulties and their most significant
barriers to seeking help often result from embarrassment and
feeling the physician would not be able to provide help [50], it is
important that the physicians and other health care team
members have the expertise to communicate effectively and
determine how the patient can be best supported or treated [36].
Sexual counseling requires interpersonal skills, knowledge,
and effective communication. The PLISSIT model can be used
in a tailored and patient-centered approach in conducting sexual
assessment andmanagement of female dyspareunia. It can assist
health care providers to understand what a patient experiences,
what matters to her, and how to improve her sexual health.
Including sexuality in the treatment of a woman experiencing
dyspareunia will ensure practice standards with the holistic care.
We hope that the recommendations in this article can provide
a framework for the health care providers to facilitate access to
recognition and treatment of female dyspareunia.References
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